A011106
|
Alliance
|
ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A011202
|
Alliance
|
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A011203
|
Alliance
|
A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCL in Postmenopausal Women with Metastatic; Estrogen Receptor Positive; HER2 Negative Breast Cancer
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
A011401
|
Alliance
|
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A011502
|
Alliance
|
A Randomized Phase III Double Blinded Placebo-Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A011801
|
Alliance
|
The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): CompassHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinb
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A012103
|
Alliance
|
OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients who Achieve pCR after Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A021302
|
Alliance
|
Impact of Early FDG-PET Directed Intervention on Preoperative Therapy for Locally Advanced Gastric Cancer: A Random Assignment Phase II Study
|
Adult CIRB - Early Phase Emphasis
|
Completed
|
|
A021502
|
Alliance
|
Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair (ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A021602
|
Alliance
|
Randomized, Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors After Progression on Everolimus (CABINET)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|